Randomized Phase 2 Study on the Relationship Between Circulating VEGF and Weekly or Every-Four-Week Zometa [zoledronic acid] in Breast Cancer Patients With Bone Metastases.

Status: Completed

Phase of Trial: Phase II/III

Latest Information Update: 10 Nov 2021

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

12 Oct 2009 Status changed from active, no longer recruiting to completed.
12 Oct 2009 Results have been presented at the 15th European Cancer Conference and the 34th Congress of the European Society for Medical Oncology.
10 Oct 2009 Results presented at the 2009 Breast Cancer Symposium

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com